Hours

Minutes

Seconds

-40%

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Latest news : BlinkLab Limited

01:59am	BlinkLab Secures US Patent for Remote Neurobehavioral Testing Platform	MT
06-16	BlinkLab to Collaborate on Ecuadorian Study on Autism, Sensorimotor Function, Nutrition in Children, Adolescents	MT
05-19	BlinkLab Enters Academic Research Agreement With Dutch Research Center	MT
04-16	BlinkLab Generates Nearly AU$18 Million From Share Placement; Shares Down 3%	MT
04-16	BlinkLab secures A$17.5m to launch autism diagnostic aid	RE
04-04	3,000,000 Performance Rights of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.	CI
04-04	35,000,000 Options of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.	CI
04-04	37,913,846 Ordinary Shares of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.	CI
03-24	BlinkLab Launches Pivotal US FDA Trial For AI Smartphone Autism Diagnostic Platform BlinkLab Dx1	CI
03-24	BlinkLab Begins Validation Program For Autism Diagnostic Aid	MT
03-23	BlinkLab Says Autism Test Integrated Into Morocco's Nationwide Autism Screening Program, Shares Fall 4%	MT
03-18	BlinkLab requests trading halt pending national Autism Screening Program announcement	RE
03-13	BlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%	MT

More news

Managers and Directors: BlinkLab Limited

Manager	Title	Age	Since
Sam Wang PRN	Corporate Officer/Principal	-	16/08/2021
Sebastiaan Koekkoek CTO	Chief Tech/Sci/R&D Officer	-	16/08/2021
Cornelis Boele CTO	Chief Tech/Sci/R&D Officer	-	16/08/2021

Director	Title	Age	Since
Hendrikus Boele BRD	Director/Board Member	-	17/12/2025
Anton Uvarov BRD	Director/Board Member	-	16/08/2021
Brian Leedman CHM	Chairman	-	14/12/2023

More insiders

BlinkLab Limited is an Australia-based digital healthcare company focused on Artificial intelligence (AI) powered diagnostics. The Company has fully developed a smartphone based diagnostic platform for autism, Attention-Deficit/Hyperactivity Disorder (ADHD), schizophrenia, and other neurodevelopmental conditions. Its product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as over 18 months old. Its pipeline includes BlinkLab Dx 1 and BlinkLab Dx N. Its BlinkLab Dx 1 is an autism diagnostic adjunct. Its BlinkLab Dx N is an ADHD diagnostic adjunct.

Employees

Sector

Software

More about the company

Quotes

Date	Price	Change	Volume
18/06/26	0.6500 $	+1.56%	58,271
17/06/26	0.6400 $	+1.59%	325,190
16/06/26	0.6300 $	-1.56%	50,178
15/06/26	0.6400 $	+0.79%	105,941
12/06/26	0.6350 $	+6.72%	97,781

Delayed Quote Australian S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.6500AUD

Average target price

1.830AUD

Spread / Average Target

+181.54%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Australian S.E. Other stock markets 06:27:57 18/06/2026 BST			5-day change	1st Jan Change
0.6500 ^AUD	+1.56%		+10.17%	-19.75%

Market Cap	99.37M 69.81M 60.83M 56.07M 52.74M 98.67M 6.58B 667M 259M 3.24B 262M 256M 11.24B	P/E 2026 *	-6.5x	P/E 2027 *	-6.5x
Enterprise Value	95.37M 67M 58.38M 53.82M 50.62M 94.7M 6.31B 640M 249M 3.11B 252M 246M 10.79B	EV / Sales 2026 *	293x	EV / Sales 2027 *	644x
Free-Float	80.71%	Yield 2026 *	-	Yield 2027 *	-

1 day	+1.56%
1 week	+10.17%
Current month	-1.52%
1 month	-4.41%
3 months	-19.75%
6 months	-22.16%
Current year	-19.75%

1 week	0.62	0.66
1 month	0.57	0.72
Current year	0.57	1.07
1 year	0.4	1.1
3 years	0.2	1.1
5 years	0.2	1.1
10 years	0.2	1.1

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BLINKLAB LIMITED	+1.56%	+10.17%	+51.16%	-	69.16M
MICROSOFT CORPORATION	+0.13%	-2.80%	-21.00%	+12.23%	2,815B
PALANTIR TECHNOLOGIES INC.	-1.65%	-1.99%	-8.21%	+713.62%	313B
CAMBRICON TECHNOLOGIES CORPORATION LIMITED	+14.20%	+22.46%	+291.79%	+907.90%	123B
CADENCE DESIGN SYSTEMS, INC.	-0.57%	+0.95%	+30.50%	+66.60%	107B
SYNOPSYS, INC.	-1.35%	-0.17%	-3.82%	+4.59%	88.41B
DATADOG, INC.	-1.60%	-4.80%	+71.49%	+130.66%	80.67B
SEA LIMITED	+0.48%	+6.52%	-41.37%	+49.13%	55.64B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	+4.93%	+12.83%	+0.33%	+72.11%	42.34B
ROBLOX CORPORATION	+7.31%	+18.49%	-49.80%	+23.37%	34.38B
Average	+2.62%	+6.10%	+32.11%	+220.02%	365.95B
Weighted average by Cap.	+0.69%	-2.39%	-5.78%	+107.67%

BlinkLab Limited Share Price

Stocks

BB1

AU0000322851

Software

Valuation: BlinkLab Limited

Chart: BlinkLab Limited

Latest news : BlinkLab Limited

Quotes and Performance

Course Extremes

Managers and Directors: BlinkLab Limited

Other Software

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

	2026 *	2027 *
Net sales	325K 228K 199K 183K 173K 323K 21.52M 2.18M 847K 10.61M 857K 839K 36.76M	145K 102K 88.76K 81.83K 76.97K 144K 9.6M 974K 378K 4.73M 382K 374K 16.4M
Net income	-6.05M -4.25M -3.7M -3.41M -3.21M -6.01M -401M -40.62M -15.77M -197M -15.95M -15.61M -684M	-7.4M -5.2M -4.53M -4.18M -3.93M -7.35M -490M -49.68M -19.29M -241M -19.52M -19.1M -837M
Net Debt	-4M -2.81M -2.45M -2.26M -2.12M -3.97M -265M -26.86M -10.43M -131M -10.55M -10.32M -452M	-6M -4.22M -3.67M -3.39M -3.18M -5.96M -397M -40.28M -15.64M -196M -15.82M -15.48M -679M